About Inotiv Co
Inotiv Co is a company based in Lafayette (United States) founded in 1974. The company has 1,955 employees as of September 30, 2023. Inotiv Co has completed 9 acquisitions, including Bolder BioPath, Envigo and Gateway Pharmacology. Inotiv Co offers products and services including Research Models, Toxicology Services, and Laboratory Diets. Inotiv Co operates in a competitive market with competitors including Novartis, Catalent, Surrozen, Biotage and Curia, among others.
- Headquarter Lafayette, United States
- Employees 1955 as on 30 Sep, 2023
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Inotiv, Inc.
-
Annual Revenue
$266.1 M (USD)392as on Sep 30, 2024
-
Net Profit
-$108.89 M (USD)-4as on Sep 30, 2024
-
EBITDA
-$6.06 M (USD)-109as on Sep 30, 2024
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
1955
as on Sep 30, 2023
-
Investments & Acquisitions
Bolder BioPath
& 8 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Inotiv Co
Inotiv Co is a publicly listed company on the NASDAQ with ticker symbol NOTV in USA, operating in the Commercial services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Inotiv Co
Inotiv Co offers a comprehensive portfolio of products and services, including Research Models, Toxicology Services, and Laboratory Diets.
Provides models for therapeutic area studies in drug development
Conducts studies to evaluate chemical safety in research
Supplies specialized diets for consistent research outcomes
People of Inotiv Co
Unlock access to complete
Unlock access to complete
Leadership Team
30 people
Sales and Marketing
26 people
Software Development Team
23 people
Finance and Accounting
10 people
Operations Team
10 people
Senior Team
5 people
Human Resources and Administration
4 people
Legal and Compliance
4 people
Unlock access to complete
Funding Insights of Inotiv Co
Detailed funding history for Inotiv Co
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Inotiv Co
Inotiv Co has strategically engaged in corporate development activities, having acquired 9 companies. Notable acquisitions include Bolder BioPath, Envigo and Gateway Pharmacology.
Investment portfolio details for Inotiv Co
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Provider of mass spectrometry based analytical solutions for drug safety and therapeutic development
|
Locked | Locked | 2017 | Locked | |
|
Drug discovery and development services are provided using research models.
|
Locked | Locked | 2015 | Locked | |
|
Preclinical CRO offering rodent models for evaluating safety and efficacy of drugs, mainly in 6 major disease areas
|
Locked | Locked | 2012 | Locked |
Complete acquisition details for Inotiv Co
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Inotiv Co
Detailed financials for Inotiv Co
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Inotiv Co Comparisons
Peer comparison for Inotiv Co
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Inotiv Co
Inotiv Co operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Novartis, Catalent, Surrozen, Biotage and Curia, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
R&D focused on manufacturing of drugs for multiple therapeutic areas
|
|
| Locked | Locked | Locked |
CDMO offering drug and biologics development services
|
|
| Locked | Locked | Locked |
Selective Wnt agonists are developed for human tissue regeneration.
|
|
| Locked | Locked | Locked |
Organic synthesis, analytical, and peptide chemistry services for drug discovery and development
|
|
| Locked | Locked | Locked |
Drug research, development, testing, and consulting services are provided.
|
|
| Locked | Locked | Locked |
Provides contract research, development, and manufacturing services for biologic drugs.
|
Detailed competitors of Inotiv Co
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Inotiv Co
Complete news archive for Inotiv Co
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Inotiv Co
Inotiv Co was founded in 1974.
Inotiv Co is headquartered in Lafayette, United States. It is registered at Lafayette, Louisiana, United States.
As of Sep 30, 2023, the latest employee count at Inotiv Co is 1,955.
Annual revenue of Inotiv Co is $266.1M as on Sep 30, 2024.
Inotiv was founded in 1974 and is headquartered in Lafayette, United States. Nonclinical and clinical development services are delivered to pharmaceutical and biotechnology clients. Regulatory support, including safety assessments and compliance guidance, is handled across various therapeutic areas. Operations encompass toxicology studies, bioanalysis, and program management, primarily serving North American markets with facilities in multiple states.
Inotiv Co offers Research Models, Toxicology Services, and Laboratory Diets.
Yes, Inotiv Co is publicly traded on NASDAQ under the ticker symbol NOTV.
Inotiv Co has made 9 acquisitions, including Bolder BioPath, Envigo, and Gateway Pharmacology.
The ticker symbol of Inotiv Co is NOTV on NASDAQ.